Biotech Catches Major Premarket Bid Following FDA Approval
2024年4月3日 - 11:25PM
AllPennyStocks.com
A Washington D.C.-based biotech is causing
quite the stir so far during Wednesday’s premarket after the
company’s Fanapt received FDA approval for the acute
treatment...
To read the full story on AllPennyStocks.com, click
here.
Vanda Pharmaceuticals (NASDAQ:VNDA)
過去 株価チャート
から 4 2024 まで 5 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
過去 株価チャート
から 5 2023 まで 5 2024